InSilicoTrials

company

About

Modeling and Simulation to accelerate development and improve safety of drugs and medical devices and significantly cut R&D costs and time

  • 11 - 50

Details

Last Funding Type
Seed
Last Funding Money Raised
$3.50M
Industries
Biotechnology,Health Care,Simulation
Founded date
May 4, 2018
Number Of Employee
11 - 50
Operating Status
Active

InSilicoTrials is an emerging startup founded in 2018 by a team of life science, cybersecurity and digital innovation experts, which aims to revolutionize Healthcare through an innovative digital simulation platform, where complex computational simulations run in an easy and cost-effective way to hyper- accelerate drug & medical device development.

We offer Pharma and MedTech companies state-of-the-art simulation tools that can highly reduce the cost and time of drugs & medical products’ development. The in silico technology can increase the quality of life of millions of patients by allowing cheaper treatments, bringing innovative drugs to the market in a shorter time, together with personalized cures and new solutions for rare diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3.50M
InSilicoTrials has raised a total of $3.50M in funding over 2 rounds. Their latest funding was raised on Jul 30, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 30, 2020 Seed $3.50M 1 United Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
InSilicoTrials is funded by 1 investors. United Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
United Ventures Yes Seed